Related Experiment Video
Updated: Aug 11, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Clinical epidemiology of cardiovascular disease in chronic kidney disease
1University Health Network-Toronto General Hospital, University of Toronto, Toronto, Canada. charmaine.lok@uhn.on.ca
Insights
Cardiovascular disease (CVD) is the leading cause of death in chronic kidney disease (CKD) patients. This review examines CVD incidence, risk factors, outcomes, and CKD
Area of Science:
- Nephrology
- Cardiology
- Epidemiology
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
- Understanding CVD epidemiology in CKD is complex due to historical challenges in defining CKD and measuring renal function.
- The interplay between renal impairment and cardiovascular disease, whether causal or consequential, remains a significant clinical question.
Purpose of the Study:
- To review the current evidence on the incidence and prevalence of CVD in patients with chronic renal insufficiency and ESRD.
- To identify and summarize risk factors associated with CVD in the CKD population.
- To examine the outcomes for patients with renal failure who also have CVD, and to assess CKD's role as a CVD risk factor.
Main Methods:
- Systematic review of existing epidemiological studies and clinical research.
- Analysis of data on CVD incidence, prevalence, risk factors, and patient outcomes across all stages of CKD.
- Evaluation of the literature concerning CKD as an independent risk factor for cardiovascular disease.
Main Results:
- Epidemiological data reveal a substantial burden of CVD across all stages of CKD.
- Specific risk factors for CVD in CKD patients are identified, contributing to poor outcomes.
- CKD is confirmed as a significant risk factor for developing cardiovascular disease.
Conclusions:
- The high prevalence of CVD in CKD underscores the urgent need for improved screening, diagnostic, and treatment strategies.
- Further research is required to fully elucidate the complex relationship between kidney function and cardiovascular health.
- Integrated approaches are necessary to manage cardiovascular risk in patients with chronic kidney disease.
Abstract:
Cardiovascular disease (CVD) is the most common cause of death in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The clinical epidemiology of CVD in CKD is challenging due to a prior lack of standardized definitions of CKD, inconsistent measures of renal function, and possible alternative effects of 'traditional' CVD risk factors in patients with CKD. These challenges add to the complexity of the role of renal impairment as the cause or the consequence of cardiovascular disease. The goal of this review is to summarize the current evidence on: (1) the incidence and prevalence of CVD in chronic renal insufficiency and in ESRD, (2) risk factors for CVD in CKD, (3) the outcomes of patients with renal failure with CVD, and (4) CKD as a risk factor for CVD. The epidemiological associations implicating the huge burden of CVD throughout all stages of CKD highlight the need to better understand and implement adequate screening, and diagnostic and treatment strategies.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

